Where does Elizabeth Iorns work?

Elizabeth Iorns is Founder/President & CEO; Chairman of the Board of Science Exchange.

What check size does Elizabeth Iorns write?

Elizabeth Iorns typically writes checks of $5K – $25K.

What companies did Elizabeth Iorns found?

Elizabeth Iorns founded Science Exchange.

Where did Elizabeth Iorns go to school?

Elizabeth Iorns studied at The Institute of Cancer Research (Ph.D., Cancer Biology); University of Auckland (B.Sc (Hons), Biomedical Science).

Elizabeth Iorns

Founder

Founder/President & CEO; Chairman of the Board at Science Exchange

San Francisco Bay Area

Writes $5K – $25K checks · typically $15K

FoundedScience Exchange · YC

About

Elizabeth Iorns is Co-Founder of Familiar Therapeutics, Science Exchange, and Unleash Therapeutics, and is the Scientific Founder of Transcripta Bio (formerly Rarebase). She holds a Ph.D. in Cancer Biology from the Institute of Cancer Research (UK) and previously served as an Assistant Professor at the University of Miami's Miller School of Medicine, where her research focused on breast cancer development and progression.

Founder/President & CEO; Chairman of the Board at Science Exchange YC S11

Intro paths

Elizabeth went through Y Combinator (Summer 2011) — any YC alum in your network can reach them through the YC community.

→

In turn, Elizabeth can intro founders to Science Exchange's investors below.

Science Exchange's investors · 8

Collaborative FundNew York · $500K – $1M checks Index VenturesSan Francisco · $540K – $10.8M checks Maverick VenturesSan Francisco · $3M – $10M checks Norwest Venture PartnersMenlo Park · $10M – $30M checks Spider CapitalSan Francisco · $500K checks Union Square Ventures (USV)New York City · $1M – $8M checks Windham Capital PartnersNew York · $1M – $5M checks Y CombinatorSan Francisco · $500K checks · since 2011

Co-founders at Science Exchange

Dan KnoxFounder & COO

Experience

FamiliarCo-Foundercurrent2026 — present
Unleash TherapeuticsCo-Foundercurrent2021 — present
Transcripta BioScientific Founder & Advisorcurrent2020 — presentPalo Alto, CA
Various StartupsAngel Investorcurrent2014 — presentSan Francisco Bay Area
Science ExchangeCEO & Co-founder2011 — 2025Palo Alto, CA
Y CombinatorPart-time partner2014 — 2020Mountain View, CA
DCAT (Drug, Chemical & Associated Technologies Association)Board Director2017 — 2018
University of MiamiAssistant Professor2010 — 2011
University of MiamiPostdoctoral Associate2008 — 2010
Institute of Cancer ResearchScientific Officer, Breakthrough Breast Cancer Research Center2003 — 2004

Skills & more

Science71Research32Lifesciences17Cell Biology22Stem Cells4Molecular Biology54Entrepreneurship39Cell12Protein Chemistry9Biochemistry9Biotechnology9Cancer3

+2 more

Cell CultureLife Sciences

From Elizabeth's professional profile.

Network7

Alexis OhanianScout

Founder & General Partner of Seven Seven Six

Buddy ArnheimScout

Investment Partner at August Capital

Chris OhScout

Investor at GreenPoint Partners

Danielle Morrill

Co-Founder & CEO, Groupthink at xfactor ventures

Justin Kan

Investor at Goat Capital

Rodrigo Ocejo

Co-founder & Partner at Avalancha Ventures

Sohail Prasad

Angel investor

Investors connected to Elizabeth in public investor directories — a warm-intro map.

Frequently asked questions

Who is Elizabeth Iorns?: Elizabeth Iorns is Co-Founder of Familiar Therapeutics, Science Exchange, and Unleash Therapeutics, and is the Scientific Founder of Transcripta Bio (formerly Rarebase). She holds a Ph.D. in Cancer Biology from the Institute of Cancer Research (UK) and previously served as an Assistant Professor at the University of Miami's Miller School of Medicine, where her research focused on breast cancer development and progression.
Where does Elizabeth Iorns work?: Elizabeth Iorns is Founder/President & CEO; Chairman of the Board of Science Exchange.
What check size does Elizabeth Iorns write?: Elizabeth Iorns typically writes checks of $5K – $25K.
What companies did Elizabeth Iorns found?: Elizabeth Iorns founded Science Exchange.
Where did Elizabeth Iorns go to school?: Elizabeth Iorns studied at The Institute of Cancer Research (Ph.D., Cancer Biology); University of Auckland (B.Sc (Hons), Biomedical Science).

Same school

Also attended The Institute of Cancer Research2

Bob CourcyChief Revenue Officer at Turtle Marc-Olivier TurgeonSenior Associate at Forbion

Also attended University of Auckland178

EgilInvestor at Investinor Giovanni PericoliniInvestor at Medicxi Francesco MonacaInvestor at Giant Ventures Global Llp Avantika GuptaPrincipal at Type One Ventures Ed BarkerPrincipal at Square Peg Capital Jono ManickamAssociate at Square Peg Capital

+ 172 more

Shared employers

+ 364 more

Also worked at University of Miami12

Ben GindhartAnalyst, IPD Capital at IPD Capital Mobi Martin DialaSeae Ventures Fellow at Seae Ventures Hershel MehtaCo-Founder & Partner at 2am VC Jason FrishmanBoard Member at Miami-Dade Innovation Authority Ramesh RaliyaChief Scientific Officer, Tidal Grow AgriScience at The Yield Lab Asia Pacific Danny CarboneroInvestment Associate at PsyMed Ventures

+ 6 more